HC Wainwright Reiterates On Pluristem After Encouraging Initial Data
July 15, 2022 at 13:32 PM EDT
YesterdayPluristem Therapeutics Inc(NASDAQ: PSTI) announced top-line results from its Phase 3 trial evaluating PLX-PAD in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.